Helena Vadi
- Molecular Biology
- Pharmacology top 1%
- Cancer Research top 10%
- Oncology
- Biochemistry top 5%
- Co-authors
- Sten OrreniusBengt JernströmPeter MoldéusLars ErnsterChristina LindM.D. BurkeRobert GrundinJorge H. Capdevila
- Topics
- Pharmacogenetics and Drug Metabolism (5 papers)Drug Transport and Resistance Mechanisms (4 papers)DNA and Nucleic Acid Chemistry (4 papers)
- Journals
- Journal of Biological ChemistryBiochemical and Biophysical Research CommunicationsEuropean Journal of Biochemistry
- Partner nations
- SwedenUnited States
In The Last Decade
Helena Vadi
19 papers receiving 611 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 286
- Pharmacology 278
- Cancer Research 187
- Oncology 134
- Biochemistry 96
Countries citing papers authored by Helena Vadi
This map shows the geographic impact of Helena Vadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Vadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Vadi more than expected).
Fields of papers citing papers by Helena Vadi
This network shows the impact of papers produced by Helena Vadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Vadi. The network helps show where Helena Vadi may publish in the future.
Co-authorship network of co-authors of Helena Vadi
This figure shows the co-authorship network connecting the top 25 collaborators of Helena Vadi. A scholar is included among the top collaborators of Helena Vadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Vadi. Helena Vadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity. | 19 |
| 2 | 17 | |
| 3 | Mixed function oxidase activities of established human colon carcinoma cell lines in the activation of cyclophosphamide. | 3 |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 20 | |
| 7 | 100 | |
| 8 | 23 | |
| 9 | Oxidation and conjugation of drugs in hepatocytes with emphasis on benzo[a]pyrene activation | 2 |
| 10 | 130 | |
| 11 | 6 | |
| 12 | 58 | |
| 13 | Formation in isolated rat liver microsomes and nuclei of benzo(a)pyrene metabolites that bind to DNA. | 65 |
| 14 | 30 | |
| 15 | 13 | |
| 16 | 2 | |
| 17 | The metabolism of benzo(alpha)pyrene in isolated rat liver cells. | 58 |
| 18 | 24 | |
| 19 | 85 |
About Helena Vadi
Helena Vadi is a scholar working on Pharmacology, Biochemistry and Oncology, having authored 19 papers that have together received 663 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Pharmacology (278 citations), Biochemistry (96 citations) and Cancer Research (187 citations). Helena Vadi has collaborated with scholars based in Sweden and United States. Frequent co-authors include Sten Orrenius, Bengt Jernström, Peter Moldéus, Lars Ernster, Christina Lind, M.D. Burke, Robert Grundin, Jorge H. Capdevila, Margareta Berggren and Benjamin Drewinko. Their work appears in journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.